ID: ALA5092150

Max Phase: Preclinical

Molecular Formula: C38H56N14O12

Molecular Weight: 900.95

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(N)=O

Standard InChI:  InChI=1S/C38H56N14O12/c1-19(47-35(62)25(4-3-13-44-38(41)42)50-36(63)27(48-20(2)53)14-21-5-7-23(54)8-6-21)33(60)52-28(15-22-16-43-18-46-22)37(64)51-26(9-11-29(39)55)34(61)45-17-30(56)49-24(32(40)59)10-12-31(57)58/h5-8,16,18-19,24-28,54H,3-4,9-15,17H2,1-2H3,(H2,39,55)(H2,40,59)(H,43,46)(H,45,61)(H,47,62)(H,48,53)(H,49,56)(H,50,63)(H,51,64)(H,52,60)(H,57,58)(H4,41,42,44)/t19-,24-,25-,26-,27-,28-/m0/s1

Standard InChI Key:  RHAIHGCXUIGQLX-LXLNESOMSA-N

Associated Targets(Human)

Leukocyte elastase 8173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 900.95Molecular Weight (Monoisotopic): 900.4202AlogP: -5.16#Rotatable Bonds: 28
Polar Surface Area: 437.99Molecular Species: ZWITTERIONHBA: 13HBD: 15
#RO5 Violations: 3HBA (Lipinski): 26HBD (Lipinski): 18#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.96CX Basic pKa: 11.58CX LogP: -8.53CX LogD: -8.56
Aromatic Rings: 2Heavy Atoms: 64QED Weighted: 0.02Np Likeness Score: 0.05

References

1. Lior Y, Shtriker E, Kahremany S, Lewis EC, Gruzman A..  (2022)  Development of anti-inflammatory peptidomimetics based on the structure of human alpha1-antitrypsin.,  228  [PMID:34763945] [10.1016/j.ejmech.2021.113969]

Source